Topic: United States
A new vaccine-like therapy that summons a host of antibodies to fight lupus has shown promise in early European trials, researchers said at a US conference on Tuesday.There are very few options for treating the potentially fatal disease in which the body's ...
LONDON (Reuters) - Britain's highest court upheld a patent on Wednesday on a gene sequence held by Human Genome Sciences related to its new lupus drug Benlysta, in a defeat for rival drugmaker Eli Lilly.The UK Supreme Court ruling chimes with similar ...
ZURICH (Reuters) - Novartis said its drug AIN457 helped alleviate the symptoms of people suffering from moderate-to-severe plaque psoriasis, the Swiss firm said on Monday based on the results of a mid-stage study.Plaque psoriasis is a common hereditary, immune-mediated systemic disorder characterized ...
For centuries physicians believed that diseases were caused by an imbalance in the "four humours" -- blood, phlegm, yellow bile and black bile.These notions were swept away in the 19th century by the advent of modern medicine.Bit by bit it laid bare ...
Vaccines used in the 2009 "swine flu" pandemic caused no perceptible rise in a neurological disorder called Guillain-Barre syndrome, a study published in the British Medical Journal (BMJ) said on Wednesday.The investigation is part of a safety probe into booster-aided flu vaccines ...
LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar" class="inform">dollar sales expectations for its makers.The companies said the European Medicines Agency had ...
LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar" class="inform">dollar sales expectations for its makers.The companies said the European Medicines Agency had ...
US health officials Wednesday announced approval of the first new drug in 56 years to treat lupus, a potentially fatal autoimmune disease affecting millions worldwide.The US Food and Drug Administration said it approved belimumab, marketed under the trade name Benlysta, an inhibitor ...
This study will evaluate an investigational drug. The research site is in Los Angeles, Calif.. This study will evaluate an investigational drug for chronic low back pain or arthritis. The research site is in Chicago, Ill.. The research site is in Burbank, ...
Lupus is a chronic autoimmune disease, a class of diseases that cause abnormal functioning of the immune system. To properly function, the nervous system requires uninterrupted blood flow to supply its tissues with nutrients and oxygen. This is more appropriately termed as ...
Photo Gallery
-
South Korea Koreas Clash
South Korean Foreign Minister Kim Sung-hwan, right, shakes hands with U.S ...AP News - -
Hawks Kings Basketball
Sacramento Kings forward Carl Landry, center, goes to the basket against Atlanta ...AP News - -
Blue Jackets Coyotes Hockey
Columbus Blue Jackets' R.J. Umberger (18) scores a goal against Phoenix ...AP News -
